Novo Nordisk

Novo Nordisk Pushes Ahead In Challenging Year
Investors.com
Tue, 09/10/13 - 04:48 pm
Novo Nordisk
Sanofi
Bristol-Myers Squibb
diabetes
Eli Lilly
MannKind
Another Prize Slips Through Novo's Hands As Big PBM Looks Elsewhere
Seeking Alpha
Thu, 09/5/13 - 08:24 am
Novo Nordisk
diabetes
FDA clears Novo Nordisk insulin pen for children
Drugstore News
Thu, 08/22/13 - 09:11 am
insulin pen
FDA
Novo Nordisk
NovoPen Echo
type 1 diabetes
MannKind's Steady Progression Towards FDA Approval Continues Unabated
Seeking Alpha
Mon, 08/19/13 - 09:43 am
MannKind
FDA
Afrezza
diabetes
insulin
inhaled insulin
Eli Lilly
Pfizer
Novo Nordisk
U.S. Insulin Prices Rise as Sanofi, Novo Await Rivals
Bloomberg
Fri, 08/16/13 - 10:42 am
insulin
diabetes
Sanofi
Novo Nordisk
Levemir
Lantus
Victoza
A Chinese Checkered History for Big Pharma
Motley Fool
Fri, 08/16/13 - 10:40 am
China
GSK
Novo Nordisk
Bristol-Myers Squibb
Pfizer
Which are pharma's top 4 innovators? Hint: It's not the big guys
Fierce Pharma
Thu, 08/15/13 - 11:59 am
innovation
Mylan
Novo Nordisk
Perrigo Company
Valeant Pharmaceuticals
This Week in Biotech
Motley Fool
Sun, 08/11/13 - 10:57 am
Celgene
CompuGen
Bayer
Isis Pharmaceuticals
Onyx
Novo Nordisk
Amgen
Novo Nordisk Getting Its Trial By Fire
Investopedia
Fri, 08/9/13 - 09:44 am
earnings
Novo Nordisk
diabetes
Teva
Eli Lilly
Sanofi
Top insulin maker Novo caught up in China's widening drug probes
Yahoo/Reuters
Thu, 08/8/13 - 08:59 am
Novo Nordisk
China
Rexahn's CEO Uses A Business-Driven Cancer Model For Shareholder Value
Seeking Alpha
Tue, 08/6/13 - 10:49 am
Rexahn
Merck
Novo Nordisk
Teva
Archexin
cancer
Oramed Expands Diabetes Platform With Oral GLP-1 Agonist
Seeking Alpha
Tue, 08/6/13 - 10:00 am
GLP-1 agonist
diabetes
Oramed
Biodel
Bristol-Myers Squibb
Eli Lilly
MannKind
Novo Nordisk
Merck
Afrezza
Januvia
Victoza
Diabetes Drugs’ Pancreas Risk Not Backed by Evidence: EMA
Bloomberg
Fri, 07/26/13 - 09:03 am
diabetes
Europe
Byetta
Bristol-Myers Squibb
Merck
Januvia
GLP-1 agonist
Novo Nordisk
Victoza
Novo Nordisk: A Pure Play In The Large And Lucrative Diabetes Care Sector
Seeking Alpha
Tue, 07/23/13 - 11:14 am
Novo Nordisk
diabetes
MannKind
Merck
The Future of Sanofi's Insulin Empire
Motley Fool
Fri, 07/19/13 - 10:17 am
Sanofi
insulin
Eli Lilly
Novo Nordisk
diabetes
U300
Lantus
LixiLan
Sun Pharma gets USFDA nod for generic diabetes tablets
Zee News, India
Sat, 07/13/13 - 12:43 pm
Sun Pharma
diabetes
repaglinide
Prandin
Novo Nordisk
generics
China's Coming Big Pharma Boom
Motley Fool
Wed, 07/10/13 - 11:07 am
China
Big Pharma
Merck
Novo Nordisk
Bayer
Pfizer
Teva
Merck's $5.7 Billion Diabetes Franchise Is Vulnerable
Seeking Alpha
Wed, 07/10/13 - 10:25 am
Merck
diabetes
Novo Nordisk
Eli Lilly
Novartis
Januvia
Dissecting the World's Biggest Diabetes Drug Stock
Motley Fool
Sat, 07/6/13 - 11:56 am
Novo Nordisk
Eli Lilly Hopes To End Novo Nordisk's Stranglehold On The GLP-1 Market
Seeking Alpha
Fri, 06/28/13 - 10:13 am
Novo Nordisk
diabetes
Eli Lilly
GLP-1 agonist
AstraZeneca
Bristol-Myers Squibb
dulaglutide
Victoza

Pages